SEC INSIDER TRANSACTIONS

Elevance Health, Inc. (ELV) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

ELV · Elevance Health, Inc.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 20 filings · fetched 2026-11-13T17:39:00Z

Recent reported activity

0purchase rows on this page

1sale rows on this page

39matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-05-19Filed 2026-05-20	Penczek Ronald WOfficer · CAO & Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan. F2 This transaction was executed in multiple trades, each at the same price of $403.13. F3 Fully vested. References: F3	M Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative	654D	0	Direct	Form 4 ↗0001659075-26-000004
2026-05-19Filed 2026-05-20	Penczek Ronald WOfficer · CAO & Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan. F2 This transaction was executed in multiple trades, each at the same price of $403.13. F3 Fully vested. References: F2	S Sale (market/private)Common Stock · Non-derivative	1,531D	403.13	Direct	Form 4 ↗0001659075-26-000004
2026-05-19Filed 2026-05-20	Penczek Ronald WOfficer · CAO & Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan. F2 This transaction was executed in multiple trades, each at the same price of $403.13. F3 Fully vested. References:	M Exercise / conversionCommon Stock · Non-derivative	877A	311.48	Direct	Form 4 ↗0001659075-26-000004
2026-05-19Filed 2026-05-20	Penczek Ronald WOfficer · CAO & Controller Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Balance includes 10.21 shares acquired on March 25, 2026 through a dividend reinvestment plan. F2 This transaction was executed in multiple trades, each at the same price of $403.13. F3 Fully vested. References: F1	M Exercise / conversionCommon Stock · Non-derivative	654A	271.27	Direct	Form 4 ↗0001659075-26-000004
2026-05-13Filed 2026-05-15	Jallal BahijaDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001730038-26-000004
2026-05-13Filed 2026-05-15	Neri Antonio FDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001648401-26-000006
2026-05-13Filed 2026-05-15	STRABLE-SOETHOUT DEANNA DDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001628280-26-035643
2026-05-13Filed 2026-05-15	DeVore Susan D.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001587697-26-000006
2026-05-13Filed 2026-05-15	Dixon Robert L JRDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001524849-26-000002
2026-05-13Filed 2026-05-15	SCHULMAN AMY WDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001438226-26-000009
2026-05-13Filed 2026-05-15	Schneider Ryan M.Director Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001420501-26-000004
2026-05-13Filed 2026-05-15	PERU RAMIRO GDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001192045-26-000002
2026-05-13Filed 2026-05-15	COLLIS STEVEN HDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001191508-26-000004
2026-05-13Filed 2026-05-15	HAY LEWIS IIIDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 Deferred stock units accrued under the Elevance Health, Inc. ("Company") Board of Directors Compensation Program. F2 The deferred stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan. References: F1, F2	A Award / grantCommon Stock · Non-derivative	563A	0	Direct	Form 4 ↗0001182705-26-000004

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.